NYSE:PAH - Platform Specialty Products Stock Price, News, & Analysis

Platform Specialty Products trades on the New York Stock Exchange (NYSE) under the ticker symbol "PAH."

Platform Specialty Products Corp (NYSE:PAH) announced its earnings results on Thursday, August, 2nd. The specialty chemicals company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.02. The specialty chemicals company earned $1 billion during the quarter, compared to the consensus estimate of $997.27 million. Platform Specialty Products had a positive return on equity of 8.48% and a negative net margin of 14.14%. The company's revenue was up 6.5% on a year-over-year basis. During the same period last year, the firm earned $0.20 earnings per share. View Platform Specialty Products' Earnings History.

6 analysts have issued 1-year price targets for Platform Specialty Products' shares. Their forecasts range from $12.00 to $15.00. On average, they anticipate Platform Specialty Products' share price to reach $13.25 in the next twelve months. This suggests a possible upside of 38.7% from the stock's current price. View Analyst Price Targets for Platform Specialty Products.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Platform Specialty Products in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Platform Specialty Products.

News articles about PAH stock have trended extremely negative on Monday, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Platform Specialty Products earned a media sentiment score of -4.2 on InfoTrie's scale. They also gave news stories about the specialty chemicals company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days.

Some companies that are related to Platform Specialty Products include Versum Materials (VSM), Element Solutions (ESI), Cabot (CBT), WD-40 (WDFC), Orion Engineered Carbons (OEC), Advanced Emissions Solutions (ADES), Flotek Industries (FTK), Pure Bioscience (PURE), HighCom Global Security (HCGS), GlyEco (GLYE), Artemis Therapeutics (ATMS) and Ener-Core (ENCR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Platform Specialty Products investors own include Two Harbors Investment (TWO), Micron Technology (MU), Uniti Group (UNIT), Alibaba Group (BABA), Freeport-McMoRan (FCX), General Electric (GE), Eagle Bulk Shipping (EGLE), Chesapeake Energy (CHK), Kinder Morgan (KMI) and Kratos Defense & Security Solutions (KTOS).

Platform Specialty Products' stock is owned by a variety of of institutional and retail investors. Top institutional investors include FMR LLC (7.11%), BlackRock Inc. (5.93%), Dimensional Fund Advisors LP (5.69%), Vaughan Nelson Investment Management L.P. (1.53%), BlueMountain Capital Management LLC (1.52%) and Morgan Stanley (1.14%). Company insiders that own Platform Specialty Products stock include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Institutional Ownership Trends for Platform Specialty Products.

PAH stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Victory Capital Management Inc., First Manhattan Co., Morgan Stanley, Private Management Group Inc., Jane Street Group LLC, Hsbc Holdings PLC and ExodusPoint Capital Management LP. Company insiders that have sold Platform Specialty Products company stock in the last year include Martin E Franklin and Pershing Square Capital Manage. View Insider Buying and Selling for Platform Specialty Products.

PAH stock was bought by a variety of institutional investors in the last quarter, including Blackstone Group L.P., Marshall Wace North America L.P., Locust Wood Capital Advisers LLC, Laurion Capital Management LP, BlackRock Inc., Dimensional Fund Advisors LP, BlueMountain Capital Management LLC and Natixis. Company insiders that have bought Platform Specialty Products stock in the last two years include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Insider Buying and Selling for Platform Specialty Products.

Shares of PAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PAH stock can currently be purchased for approximately $9.55.

Platform Specialty Products has a market capitalization of $2.75 billion and generates $3.78 billion in revenue each year. The specialty chemicals company earns $-296,200,000.00 in net income (profit) each year or $0.76 on an earnings per share basis.

The official website for Platform Specialty Products is http://www.platformspecialtyproducts.com/.

Platform Specialty Products' mailing address is 1450 CENTREPARK BLVD SUITE 210, WEST PALM BEACH FL, 33401. The specialty chemicals company can be reached via phone at (561) 207-9600.